JPRN-UMIN000034028
Recruiting
未知
Special Drug Use Results Surveillance for the use of Odefsey in pregnant women - Special Drug Use Results Surveillance for the use of Odefsey in pregnant women
ConditionsHIV/AIDS
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HIV/AIDS
- Sponsor
- Janssen Pharmaceutical K.K.
- Enrollment
- 3
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Special drug use results surveillance for the use of SIMPONI in ulcerative colitisulcerative colitisJPRN-UMIN000027542Janssen Pharmaceutical K.K.300
Recruiting
Not Applicable
Special drug use-results surveillance <Patients with cold agglutinin disease>Cold agglutinin diseaseJPRN-UMIN000049607sanofi K.K.100
Completed
Not Applicable
Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg TabletsAttention deficit hyperactivity disorder (ADHD)JPRN-UMIN000015900Janssen Pharmaceutical K.K500
Completed
Not Applicable
Special Drug Use-results Surveillance for long term administration of XEPLION (Paliperidone Palmitate 1 month formulation), 25mg/ 50mg/ 75mg/ 100mg/ 150mg syringeSchizophreniaJPRN-UMIN000018665Janssen Pharmaceutical K.K.1,050
Recruiting
Phase 4
Post-marketing Surveillance Protocol Number; CABL001A1401Chronic myeloid leukemia resistant or intolerant to pretreatment drugsJPRN-jRCT2031220191Toshiya Sugimoto440